V08CA03 - Gadodiamide |
Not porphyrinogenic |
NP |
Rationale
Gadodiamide is excreted unchanged though the kidneys.
Chemical description
Gadodiamide is a nonionic gadolinium chelate.
Therapeutic characteristics
Gadodiamide is used as a magnetic resonance contrast medium. It is administered intravenously. Nausea is a common adverse reaction of gadodiamide that can be confused with an acute porphyric attack.
Hepatic exposure
Not relevant.
Metabolism and pharmacokinetics
Gadodiamide is rapidly distributed into extracellular fluid. About 96% of a dose is excreted unchanged in the urine within 24 hours. No metabolites have been found.
Similar drugs
References
| # | Citation details | PMID |
|---|---|---|
| * | Drug reference publications | |
| 1. | Sweetman SC, editor. Martindale: The complete drug reference. Gadodiamide. Pharmaceutical Press 2009.
|
|
| * | Summary of Product Characteristics | |
| 2. | Norwegian medicines agency. Summary of Product Characteristics (SPC). Omniscan.
|
|
Tradenames
Omniscan 
Omniscan 
Omniscan 
Omniscan 
Omniscan 
Omniscan 
Omniscan 
Omniscan 
Gadolinium 
Omniscan 
Gadodiamida 
Gadodiamide